HEK293-6E Transfection Protocol Optimization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing HEK293-6E protocols for expressing recombinant proteins, particularly multispecific antibodies, require multiple steps, significant amounts of DNA, and the use of FBS, which limits resource efficiency and throughput.
Innovation Solution
The development of optimized HEK293-6E protocols, such as Grace_v2 and Grace_v3, which reduce the DNA requirement by 50%, eliminate the need for FBS, and simplify the process by eliminating the need for sodium valproic acid, thereby enhancing resource efficiency and throughput.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If the traditional HEK293-6E protocol is used with multiple feeding steps and VPA addition, then protein expression yield is maintained, but the process complexity and resource consumption increase
Solution Approach 1:
The patent optimizes the DNA:cell ratio parameter to 0.25 μg:1×10^6 cells, which is 50% less than the traditional protocol. This parameter change reduces resource consumption while maintaining transfection efficiency and protein expression yield through precise control of transfection conditions
Solution Approach 2:
The patent extracts and eliminates unnecessary process steps from the traditional protocol, specifically removing the VPA addition step and reducing feeding steps. This simplification removes complexity without compromising protein expression outcomes, thereby increasing throughput
2Ease of manufacture
If FBS is used in the cell culture media, then cell growth is supported, but resource consumption and process complexity increase
Solution Approach 1:
The patent replaces expensive FBS with a defined media formulation that uses cheaper, more stable components. This substitution reduces resource consumption and simplifies the manufacturing process by eliminating the need for FBS-related quality control and storage requirements
3Productivity
If multiple experimental steps including VPA addition are performed, then protein expression is optimized, but experimental time and complexity increase
Solution Approach 1:
The patent extracts and removes the VPA addition step from the experimental protocol. This elimination reduces the number of experimental steps and associated complexity while maintaining comparable protein expression yields, thereby increasing experimental throughput
Solution Approach 2:
The patent merges multiple separate operations into a simplified protocol where feeding and transfection are optimized as integrated steps. This consolidation reduces the total number of discrete operations required, decreasing experimental complexity and increasing throughput
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These optimized protocols achieve comparable protein yields and quality to previous methods while reducing experimental steps and resource consumption, thereby improving flexibility and efficiency in recombinant protein production.
Implementation Method 1
performing a transfection step by contacting the cells with a liposome/DNA complex
Data Source
AI summary
The present invention relates to an optimized method of transfecting cells that requires less steps and less DNA than previously disclosed methods. In addition, the method allows for less days in the laboratory for scientists.